Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Pfizer on Friday said it would stop developing the twice-daily version of its experimental weight loss pill after obese patients… Read More »Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects